Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Streptococcus pyogenes Su strain cells treated with benzylpenicillin

EU orphan designation number: EU/3/09/714
Active ingredient: Streptococcus pyogenes Su strain cells treated with benzylpenicillin
Indication: Treatment of congenital lymphatic malformations
Sponsor: Theradex (Europe) Ltd.
7 Pelham Court, Broadfield, Crawley, West Sussex RH11 9SH, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
02/02/2010 Centralised Orphan - Designation EMEA/OD/056/09 (2010)713 of 29/01/2010
23/06/2011 Centralised Orphan - Removal of orphan designation from Community Register